HD LABS Tirzepatide Compound Peptide Pen 30mg

Weight Management • Appetite Control • Metabolic Support

Advanced Dual GIP + GLP-1 Receptor Agonist

HD Labs Tirzepatide 30mg represents a significant advancement in metabolic health. As a dual receptor agonist, it targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) pathways to offer superior weight management and glycemic control compared to single-mechanism therapies.

Key Benefits

• Strong Appetite Suppression: Significantly reduces hunger and caloric intake.
• Optimal Blood Sugar Control: Helps maintain stable glucose levels.
• Accelerated Fat Loss: Promes rapid reduction of body fat.
• Reduced "Food Noise": Minimizes cravings and obsessive thoughts about food.

Disclaimer

This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.

Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.